A phase I study of ispinesib, a kinesin spindle protein inhibitor, administered weekly for three consecutive weeks of a 28-day cycle in patients with solid tumors (Q82485618)
scientific article published on 13 January 2010
Language:
(P31) (Q13442814)
(P304) 467-472
(P407) (Q1860)
(P433) 3
(P478) 29
(P577) Wednesday, January 13, 2010
(P1433) (Q2312231)
(P1476) "A phase I study of ispinesib, a kinesin spindle protein inhibitor, administered weekly for three consecutive weeks of a 28-day cycle in patients with solid tumors" (language: en)
(P2093) Howard A Burris
Suzanne F Jones
Daphne D Williams
Steven J Kathman
Jeffrey P Hodge
Lini Pandite
Peter T C Ho
Scott A Boerner
Patricia Lorusso
(P2860) (Q36623076)
(Q34318656)
(Q40470308)
(Q40208980)
(Q38429571)
(Q36107322)
(Q33214719)
(Q34441105)
(Q24685871)
(Q36494207)
(Q24633398)
(Q24315026)
(Q34434425)
(Q46166691)
(Q38428919)
(Q33243569)
other details
description scientific article published on 13 January 2010

External Links